Green Angel Syndicate has made a significant investment in one of the most important recycling breakthroughs this year. Descycle has just closed an oversubscribed pre-Series A round.  Coupled with a grant from the UK Government, this will be deployed to continue research into the application of DES in the recycling and minerals processing sectors.

Revolutionary Oxford biotechnology company HydRegen pursues a huge growth opportunity to decarbonise the global chemical manufacturing and pharmaceutical industries.

Centuro Global, the one-stop-shop for businesses looking to expand overseas, will expand its offering as a cost-effective alternative to larger consultancy firms following a successful fundraising round.

The fast-growing scale-up has landed £3.3million from Mercia, having landed contracts with some of the leading companies in the world, exceeded sales targets, and tripled headcount over a period of phenomenal acceleration.

Get ready to elevate your angel investing game and expand your network at the EBAN 2023 Annual Congress in Thessaloniki, Greece, from May 24-26!

Check out our latest investment ad from Harniman's, a new range of oral sprays with a unique mixture of health-boosting ingredients.  They are currently fund raising to support the next stage of growth.  To view the full investment ad go to our Funding Pages website.

Canopey, an online marketplace for environmentally sustainable and eco-conscious brands, has secured investment from two leading technology executives.

Green Angel Syndicate portfolio companies have announced that Zedify is to partner with New Motion Labs following "overwhelmingly good" EnduoTM Cargo trials.

As the energy crisis continues to paint a bleak picture across the economic landscape, London-based residential energy services provider Hometree has secured $46m in equity funding to help millions of homeowners enjoy sustainable living by offering low carbon energy solutions in the home.

SOLASTA Bio, a UK agritech specialising in the next generation of green insecticides has secured a further round of investment totalling £4 million to scale up the development of its unique nature-inspired pesticides, the first of their kind to be developed worldwide.

Scottish technology firm Bioliberty has secured £2.2 million in funding to develop a unique soft robotic glove which can restore upper limb mobility in patients following a stroke. The funding round was led by Archangels, with participation from Eos Advisory, Old College Capital and Hanna Capital SEZC.

Oxford Innovation EIS Growth Fund alongside OION angel investors, have invested in the £1.2 million oversubscribed funding round for OSSTEC, the orthopaedics company developing bone healing implants.

Its patented platform technology, proven over 8 years of research and development at Imperial College London, reduces implant loosening and bone loss post-surgery. OSSTEC’s world leading team combining engineers and surgeons, has developed the first fully porous implants to stimulate long-term bone growth.

Blackfinch Ventures has completed investment deals valued at £11m into 17 early-stage UK companies up to the end of the tax year.